CRVS icon

Corvus Pharmaceuticals

91 hedge funds and large institutions have $167M invested in Corvus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 8 reducing their positions, and 28 closing their positions.

Holders
91
Holders Change
+4
Holders Change %
+4.6%
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
33
Increased
32
Reduced
8
Closed
28
Calls
$532K
Puts
$900K
Net Calls
-$368K
Net Calls Change
-$3.16M
Name Market Value Shares Shares
Change
Shares
Change %
EC
101
EntryPoint Capital
New York
-53,745 Closed
JG
102
Jain Global
New York
-48,145 Closed
JF
103
Jump Financial
Illinois
-45,013 Closed
SSA
104
Schonfeld Strategic Advisors
New York
-39,783 Closed
QC
105
Quantessence Capital
New York
-36,421 Closed
CGIM
106
Cannon Global Investment Management
Florida
-35,000 Closed
LP
107
LMR Partners
United Kingdom
-29,858 Closed
Simplex Trading
108
Simplex Trading
Illinois
-26,990 Closed
Verition Fund Management
109
Verition Fund Management
Connecticut
-24,413 Closed
Dimensional Fund Advisors
110
Dimensional Fund Advisors
Texas
-22,793 Closed
OC
111
Oppenheimer & Co
New York
-22,534 Closed
QOP
112
Quinn Opportunity Partners
Virginia
-22,327 Closed
BHCM
113
Brevan Howard Capital Management
Jersey
-21,738 Closed
UOC
114
UBS O'Connor
Illinois
-20,850 Closed
XT
115
XTX Topco
Cayman Islands
-14,958 Closed
CM
116
Capula Management
Cayman Islands
-14,793 Closed
Capstone Investment Advisors
117
Capstone Investment Advisors
New York
-12,644 Closed
Group One Trading
118
Group One Trading
Illinois
-11,895 Closed
PCM
119
Prelude Capital Management
New York
-10,027 Closed
IC
120
Ikarian Capital
Texas
Wolverine Trading
121
Wolverine Trading
Illinois
BGI
122
B Group Inc
Texas
BFM
123
Boothbay Fund Management
New York